Dana-farber Cancer Institute

Based in MA

🤖

AI Overview

With $1.8M in lobbying spend across 25 quarterly filings, Dana-farber Cancer Institute is a significant lobbying presence. Their lobbying covers 8 issue areas. Active from 2021 to 2025.

$1.8M
Total Spend
5
Years Active
1
Firms Hired
2
Lobbyists Deployed
8
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$120K
2022$489K
2023$282K
2024$547K
2025$344K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues, MED, Taxation, Medicare/Medicaid and 3 more

  • ARPA-H initiative, funding for National Institutes of Health, National Cancer Institute, Telehealth issues, etc.
  • Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitabl
  • Funding related to biomedical and cancer research and innovation at the NIH and NCI including HR 4502, Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Dev

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.